Clinical Trial Update: Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating AR01 versus placebo for pain relief in acute otitis media was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• AR01

Snippet

Sponsor: Arbor Pharmaceuticals, Inc. | Conditions: Acute Otitis Media | Phase 3 | Status: TERMINATED